Today's CVN Engle progeny trading card features one of the leading defense attorneys in Florida's landmark litigation.
0 Comments Click here to read/write comments
Topics: Negligence, Products Liability, tobacco, Engle Litigation Trading Cards, Engle Progeny, Florida
Robert Shields argues that punitive damages should be imposed against Philip Morris in a suit by his client, Mary Brown. The jury awarded more than $6.3 million in compensatory damages but declined to award punitives in the case.
0 Comments Click here to read/write comments
Topics: Negligence, Products Liability, tobacco, Engle Progeny, Florida, Engle Progeny Review, Dupre v. R.J. Reynolds, Brown v. Philip Morris USA
Robert Shields details the smoking history of Rayfield Brown, who died of lung cancer in 1995. Shields is representing Brown's widow as trial opened on damages Thursday.
0 Comments Click here to read/write comments
Topics: Negligence, Products Liability, tobacco, Engle Progeny, Florida, Engle Progeny Review, Russo v. Philip Morris, Ryan v. R.J. Reynolds, Brown v. Philip Morris USA
William Geraghty delivers closing arguments in Tina Russo's wrongful death suit against R.J. Reynolds and Geraghty's client, Philip Morris. The tobacco makers prevailed against Russo's claim that their deception about the dangers of smoking led to her mother's nicotine addiction, respiratory disease, and death. Click here to watch the trial on demand.
0 Comments Click here to read/write comments
Topics: Negligence, Products Liability, tobacco, Engle Progeny, Florida, Russo v. Philip Morris
In the nearly nine years since the Florida Supreme Court decertified Engle v. Liggett Group Inc., CVN has broadcast more than 120 Engle progeny proceedings. Harnessing the data from that library of cases, we first introduced our Engle Trading Cards in 2011 as a light-hearted way to highlight the key individuals and trials across this landmark litigation. Last September, we introduced Series 2, a 12-card set that included CVN's Engle Attorneys of the Year and met unprecedented popularity.
0 Comments Click here to read/write comments
